K. Hoffmann

461 total citations
18 papers, 282 citations indexed

About

K. Hoffmann is a scholar working on Surgery, Pharmacology and Epidemiology. According to data from OpenAlex, K. Hoffmann has authored 18 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 4 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in K. Hoffmann's work include Pharmacogenetics and Drug Metabolism (3 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). K. Hoffmann is often cited by papers focused on Pharmacogenetics and Drug Metabolism (3 papers), Liver Disease and Transplantation (3 papers) and Liver Disease Diagnosis and Treatment (2 papers). K. Hoffmann collaborates with scholars based in Germany, United States and Switzerland. K. Hoffmann's co-authors include G. Scollo‐Lavizzari, J Bircher, Urs Peter Haemmerli, W. A. Ritschel, Henry S.I. Tan, Michael Emmett Brady, C G Regårdh, B. Edgar, H. Heidemann and Dirk Hagemann and has published in prestigious journals such as The American Journal of Medicine, Journal of Molecular Medicine and Scandinavian Journal of Gastroenterology.

In The Last Decade

K. Hoffmann

18 papers receiving 253 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K. Hoffmann Germany 7 67 57 43 40 37 18 282
James M. Harkema United States 9 61 0.9× 23 0.4× 57 1.3× 55 1.4× 36 1.0× 13 351
Józef Bogdał United States 6 91 1.4× 65 1.1× 52 1.2× 89 2.2× 24 0.6× 8 286
Craig J. McClain United States 5 52 0.8× 25 0.4× 41 1.0× 29 0.7× 77 2.1× 6 312
K O Lewis United Kingdom 10 50 0.7× 52 0.9× 92 2.1× 42 1.1× 156 4.2× 17 501
Mara Simoncini Italy 10 29 0.4× 82 1.4× 96 2.2× 93 2.3× 35 0.9× 13 375
Edward A. Sasse United States 9 45 0.7× 16 0.3× 50 1.2× 29 0.7× 39 1.1× 17 471
G. Idéo Italy 10 83 1.2× 120 2.1× 111 2.6× 33 0.8× 20 0.5× 22 332
David M. Tennent United States 9 23 0.3× 31 0.5× 36 0.8× 76 1.9× 38 1.0× 16 303
D Takoudas Greece 11 39 0.6× 68 1.2× 47 1.1× 156 3.9× 10 0.3× 28 362
Ansar A. Khan India 9 94 1.4× 25 0.4× 52 1.2× 61 1.5× 29 0.8× 20 338

Countries citing papers authored by K. Hoffmann

Since Specialization
Citations

This map shows the geographic impact of K. Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hoffmann more than expected).

Fields of papers citing papers by K. Hoffmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hoffmann. The network helps show where K. Hoffmann may publish in the future.

Co-authorship network of co-authors of K. Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of K. Hoffmann. A scholar is included among the top collaborators of K. Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Hoffmann. K. Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ganser, Arnold, W.-K. Hofmann, Oliver G. Ottmann, et al.. (1997). 174 Intensive chemotherapy (idarubicin, ARA-C, VP-16) combined with G-CSF-priming yields high remission rates in patients with advanced MDS and high-risk AML. Leukemia Research. 21(1). S46–S46. 1 indexed citations
2.
Pfaffenbach, B, R. J. Adamek, Dirk Hagemann, et al.. (1996). Effect of progressive systemic sclerosis on antral myoelectrical activity and gastric emptying.. PubMed. 34(9). 517–21. 12 indexed citations
3.
Altmeyer, Peter, et al.. (1995). Interferometry: a new method for no-touch measurement of the surface and volume of ulcerous skin lesions.. Acta Dermato Venereologica. 75(3). 193–197. 7 indexed citations
4.
Adamek, R. J., et al.. (1994). Long-term manometry of tubular esophagus in progressive systemic sclerosis. Journal of Molecular Medicine. 72(5). 343–9. 2 indexed citations
5.
Wensing, Georg, K. Hoffmann, & H. Heidemann. (1993). Antipyrine elimination in patients with alcoholic and non-alcoholic cirrhosis.. PubMed. 31(1). 15–9. 6 indexed citations
6.
Mönig, Heiner, K. Hoffmann, E. E. Ohnhaus, & H. M. Schulte. (1992). Ranitidine treatment and cortisol metabolism in man. European Journal of Drug Metabolism and Pharmacokinetics. 17(1). 9–12. 2 indexed citations
7.
Schroeder, P, et al.. (1990). Metabolic changes and liver function after orthotopic small-bowel transplantation.. PubMed. 22(6). 2452–2452. 1 indexed citations
8.
Regårdh, C G, et al.. (1990). Pharmacokinetics and biotransformation of 1,4-dihydropyridine calcium antagonists. 12. 41–86. 17 indexed citations
9.
Mayersohn, Michael, et al.. (1988). Pharmacokinetics of moclobemide (Ro 11-1163) in patients with liver cirrhosis. Pharmacological Research Communications. 20. 123–124. 1 indexed citations
10.
Skånberg, Inger, K. Hoffmann, & C G Regårdh. (1986). Pharmacokinetics and Metabolism of Omeprazole in Animals. Scandinavian Journal of Gastroenterology. 21(sup118). 92–93. 4 indexed citations
11.
Ritschel, W. A. & K. Hoffmann. (1981). Pilot Study on Bioavailability of Coumarin and 7‐Hydroxycoumarin upon Peroral Administration of Coumarin in a Sustained‐Release Dosage Form. The Journal of Clinical Pharmacology. 21(7). 294–300. 19 indexed citations
12.
Hoffmann, K., et al.. (1980). Diabetische Retinopathie bei Kindern und Jugendlichen. Ihre Abhängigkeit von der Stoffwechseleinstellung*. Klinische Monatsblätter für Augenheilkunde. 177(10). 482–486. 4 indexed citations
13.
Ritschel, W. A., et al.. (1977). Pharmacokinetics of coumarin and its 7-hydroxy-metabolites upon intravenous and peroral administration of coumarin in man. European Journal of Clinical Pharmacology. 12(6). 457–461. 69 indexed citations
14.
Černý, Jan, et al.. (1977). [Mycotic aneurysms of the brachial artery].. PubMed. 56(1). 44–8. 1 indexed citations
15.
Heberer, G., et al.. (1976). Operative Behandlung entzündlicher Dickdarmerkrankungen: Colitis ulcerosa, Morbus Crohn, Divertikulitis*. DMW - Deutsche Medizinische Wochenschrift. 101(16). 605–611. 1 indexed citations
16.
Hoffmann, K., et al.. (1973). [Early and late reintervention following resection for gastroduodenal ulcer].. PubMed. 44(1). 7–14. 4 indexed citations
17.
Bircher, J, Urs Peter Haemmerli, G. Scollo‐Lavizzari, & K. Hoffmann. (1971). Treatment of chronic portal-systemic encephalopathy with lactulose. The American Journal of Medicine. 51(2). 148–159. 121 indexed citations
18.
Hoffmann, K., et al.. (1969). Postoperative infection of wounds by anaerobes.. PubMed. 14(1). 31–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026